ScholarIQanswers from OpenAlex

Rapamycin Attenuates Atherosclerotic Plaque Progression in Apolipoprotein E Knockout Mice

PaperCitations, authors & open-access status

Rapamycin Attenuates Atherosclerotic Plaque Progression in Apolipoprotein E Knockout Mice is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Rapamycin Attenuates Atherosclerotic Plaque Progression in Apolipoprotein E Knockout Mice have?

ScholarIQcitation count

Rapamycin Attenuates Atherosclerotic Plaque Progression in Apolipoprotein E Knockout Mice has 101 citations in the OpenAlex counts ScholarIQ stores.

When was Rapamycin Attenuates Atherosclerotic Plaque Progression in Apolipoprotein E Knockout Mice published?

ScholarIQyear

Rapamycin Attenuates Atherosclerotic Plaque Progression in Apolipoprotein E Knockout Mice has 2005 year in the ScholarIQ index.

What is the open-access status of Rapamycin Attenuates Atherosclerotic Plaque Progression in Apolipoprotein E Knockout Mice?

ScholarIQoa status

Rapamycin Attenuates Atherosclerotic Plaque Progression in Apolipoprotein E Knockout Mice has closed oa status in the ScholarIQ index.

What is the DOI of Rapamycin Attenuates Atherosclerotic Plaque Progression in Apolipoprotein E Knockout Mice?

ScholarIQdoi

The DOI for Rapamycin Attenuates Atherosclerotic Plaque Progression in Apolipoprotein E Knockout Mice is on the source record.

What is the PMID of Rapamycin Attenuates Atherosclerotic Plaque Progression in Apolipoprotein E Knockout Mice?

ScholarIQpmid

The PMID for Rapamycin Attenuates Atherosclerotic Plaque Progression in Apolipoprotein E Knockout Mice is on the source record.

What is the OpenAlex record for Rapamycin Attenuates Atherosclerotic Plaque Progression in Apolipoprotein E Knockout Mice?

ScholarIQopenalex

The OpenAlex for Rapamycin Attenuates Atherosclerotic Plaque Progression in Apolipoprotein E Knockout Mice is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial